Literature DB >> 19251787

Clinical relevance of constant power exercise duration changes in COPD.

L Puente-Maestu1, F Villar, J de Miguel, W W Stringer, P Sanz, M L Sanz, J García de Pedro, Y Martínez-Abad.   

Abstract

The endurance time during constant high work-rate exercise (t(LIM)) is used to assess exercise capacity in patients with chronic obstructive pulmonary disease and as an outcome measure for pulmonary rehabilitation. Our study was designed to establish the minimum clinically important difference for the t(LIM). t(LIM) was measured in 105 patients (86 males) before and after an 8-week outpatient pulmonary rehabilitation programme. Subjects were asked to identify, from a five-point Likert scale, the perceived change in their exercise performance immediately upon completion of the exercise tests. The scale ranged from "better" to "worse". The mean+/-sd age was 64+/-5 yrs, forced expiratory volume in 1 s (FEV(1)) 47+/-10% and FEV(1)/forced vital capacity 54.7+/-16.3%. Baseline t(LIM) at 75% of the peak work rate was 397+/-184 s, which increased by 62+/-63% after rehabilitation. In subjects who felt their exercise tolerance was "slightly better", the mean improvement was 34% in the relative improvement over the baseline value (95% CI 29-39)% or 101 (86-116) s compared with 121 (109-134)% in those who reported that their exercise tolerance was "better" and 8 (2-14)% in those who felt their exercise tolerance was "about the same". Minimum clinically important improvement for t(LIM) averaged approximately 33% of baseline. Patients were able to distinguish at least one further additional level of benefit at 120% of baseline.

Entities:  

Mesh:

Year:  2009        PMID: 19251787     DOI: 10.1183/09031936.00078308

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  19 in total

1.  Dietary nitrate supplementation improves exercise performance and decreases blood pressure in COPD patients.

Authors:  Michael J Berry; Nicholas W Justus; Jordan I Hauser; Ashlee H Case; Christine C Helms; Swati Basu; Zachary Rogers; Marc T Lewis; Gary D Miller
Journal:  Nitric Oxide       Date:  2014-10-27       Impact factor: 4.427

Review 2.  Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease.

Authors:  Kate McKeage
Journal:  Drugs       Date:  2012-03-05       Impact factor: 9.546

Review 3.  Impact of bronchodilator therapy on exercise tolerance in COPD.

Authors:  B Aguilaniu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-04-07

Review 4.  Optimal intensity and type of leg exercise training for people with chronic obstructive pulmonary disease.

Authors:  Rahizan Zainuldin; Martin G Mackey; Jennifer A Alison
Journal:  Cochrane Database Syst Rev       Date:  2011-11-09

5.  Once-daily NVA237 improves exercise tolerance from the first dose in patients with COPD: the GLOW3 trial.

Authors:  Kai M Beeh; Dave Singh; Lilla Di Scala; Anton Drollmann
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-07-31

6.  Respiratory muscle training with normocapnic hyperpnea improves ventilatory pattern and thoracoabdominal coordination, and reduces oxygen desaturation during endurance exercise testing in COPD patients.

Authors:  Eva Bernardi; Luca Pomidori; Faisy Bassal; Marco Contoli; Annalisa Cogo
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2015-09-10

7.  Aclidinium improves exercise endurance, dyspnea, lung hyperinflation, and physical activity in patients with COPD: a randomized, placebo-controlled, crossover trial.

Authors:  Kai M Beeh; Henrik Watz; Luis Puente-Maestu; Luis de Teresa; Diana Jarreta; Cynthia Caracta; Esther Garcia Gil; Helgo Magnussen
Journal:  BMC Pulm Med       Date:  2014-12-23       Impact factor: 3.317

8.  Effect of theophylline on exercise capacity in COPD patients treated with combination long-acting bronchodilator therapy: a pilot study.

Authors:  Nha Voduc; Gonzalo G Alvarez; Kayvan Amjadi; Caroline Tessier; Elham Sabri; Shawn D Aaron
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-03-29

9.  Characteristics and determinants of endurance cycle ergometry and six-minute walk distance in patients with COPD.

Authors:  Vasileios Andrianopoulos; Scott S Wagers; Miriam T J Groenen; Lowie E Vanfleteren; Frits M E Franssen; Frank W J M Smeenk; Ioannis Vogiatzis; Emiel F M Wouters; Martijn A Spruit
Journal:  BMC Pulm Med       Date:  2014-05-31       Impact factor: 3.317

10.  The lungs need to be deflated: effects of glycopyrronium on lung hyperinflation in COPD patients.

Authors:  Claudio M Sanguinetti
Journal:  Multidiscip Respir Med       Date:  2014-04-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.